Nvidia Stock To $200 As H200 Exports To China Resume?

Nvidia has secured assurances from the Trump administration to resume sales of its H20 AI chips to China, reversing a prior ban and potentially recouping a $4.5 billion write-off from unsold inventory. This move, following CEO Jensen Huang's meeting with President Trump, marks a significant win for Nvidia, as China is a critical market that relies heavily on its AI hardware and has historically used gray market channels to acquire chips. While the resumption of direct sales could boost Nvidia's earnings and provide a clearer growth path, the article cautions that the stock is currently richly valued and future growth may face headwinds from potential plateaus in AI model performance gains and increased competition in inference workloads.

Analysis

Nvidia has secured assurances from the Trump administration to resume sales of its H20 AI chip to the Chinese market, a significant development following a prior ban. This regulatory relaxation could enable the company to reverse a $4.5 billion write-off taken on unsold H20 inventory, potentially providing a material boost to earnings. The Chinese market is strategically critical, generating $17 billion, or approximately 13% of Nvidia's total revenue in fiscal 2025, and a return to direct sales could stabilize this revenue stream away from gray market channels. Despite this positive catalyst, significant caution is warranted. The stock, trading near $170 per share after an 18% year-to-date increase, is viewed as overvalued, with a fair value estimate cited at $130. While its forward P/E of 40x is deemed reasonable against a 55% consensus revenue growth forecast, several headwinds loom. The analysis suggests the market may be shifting from AI training to inference, an environment where cost-efficiency is prioritized and competitors like AMD, with its MI series chips and improving ROCm software platform, could become more competitive. Furthermore, the potential for plateauing performance gains from larger AI models and a general cooling of the FOMO-driven rally present risks to future growth normalization and earnings expansion.

Key Decisions for Investors

• Investors should weigh the short-term positive catalyst of resumed China sales and a potential $4.5 billion earnings boost against the explicit valuation concerns, with the stock trading roughly 20% above the cited fair value estimate.
• Monitor the competitive landscape for a potential shift from AI training to inference workloads, paying close attention to market penetration by AMD's MI series chips as a leading indicator of eroding market share.
• Given the stock's valuation and the risk of growth normalization, consider trimming positions or implementing hedging strategies to protect against downside risk if the 'fear-of-missing-out' sentiment wanes.
• Recognize that revenue from China remains subject to volatile U.S. trade policy, and this recent approval, while positive, underscores a persistent geopolitical risk factor that must be continuously evaluated.